title: Assessment of Venous Thromboembolism Prophylaxis in Neurological Patients with Restricted Mobility - VTE-NEURO Study.
abstract: The authors present the data of a medical registry which evaluated if the physicians assess VTE risk in stroke patients, during hospitalization period and at hospital discharge and if the thromboprophylaxis is used according to National Guidelines for VTE Prophylaxis. 884 patients with acute ischemic stroke patients were enrolled between June 2010 and December 2011, from 62 centers, 51.4% male and 48.6% female with mean age 70.07 years (68.25 years in the male group and 71.92 years in the female one). There were two co-primary endpoints: the percentage of patients at risk for VTE at hospital admission assessed by the physician, and the percentage of patients with risk factors for VTE that persist at hospital discharge from the total number of patients hospitalized with ischemic stroke. The secondary endpoints were: the percentage of hospitalized patients receiving prophylaxis according to the National Guidelines of VTE Prophylaxis from the total number of patients at risk of VTE, the percentage of hospitalized patients with VTE risk receiving recommendation for thromboprophylaxis at discharge, the duration and the type of VTE prophylaxis in hospitalized patients, the duration and the type of VTE prophylaxis at discharge.
  
  
  RESULTS
  879 (99.4%) of the total number of patients at risk of VTE have received prophylaxis during hospitalization. The most frequently types of prophylaxis used during hospitalisation were LMWH in 96.3% of the patients and mechanic method in 16.6% that were in accordance with the National Guidelines of VTE Prophylaxis recommendations.
  
  
  CONCLUSIONS
  There is a clear improvement in both assessment and thromprophylaxis recommendation in acute stroke patients with restricted mobility at VTE risk and in our country. LMWH is preferred to unfractionated heparin for venous thromboembolism prophylaxis in this high-risk patient population in view of its better clinical benefits to risk ratio and convenience of once daily administration.
authors.affiliation: Department of Neurology, Emergency University Hospital, Bucharest, Romania.
authors.forename: Ovidiu
authors.initials: O
authors.lastname: Bajenaru
authors.affiliation: Department of Neurology, Emergency University Hospital, Bucharest, Romania.
authors.forename: Florina
authors.initials: F
authors.lastname: Antochi
authors.affiliation: Department of Neurology, Emergency County Clinical Hospital, Târgu-Mures, Romania.
authors.forename: Rodica
authors.initials: R
authors.lastname: Balasa
authors.affiliation: Department of Neurology, Colentina Clinical Hospital, Bucharest, Romania.
authors.forename: Ioan
authors.initials: I
authors.lastname: Buraga
authors.affiliation: Department of Neurology, Clinical Hospital of Medical Rehabilitation, Cluj-Napoca, Romania.
authors.forename: Sanda
authors.initials: S
authors.lastname: Patrichi
authors.affiliation: Department of Neurology, Emergency County Clinical Hospital, Timisoara, Romania.
authors.forename: Mihaela
authors.initials: M
authors.lastname: Simu
authors.affiliation: Department of Neurology, Emergency County Clinical Hospital, Târgu-Mures, Romania.
authors.forename: Szatmari
authors.initials: S
authors.lastname: Szabolcs
authors.affiliation: Department of Neurology, Emergency University Hospital, Bucharest, Romania.
authors.forename: Cristina
authors.initials: C
authors.lastname: Tiu
authors.affiliation: Department of Neurology, Clinical Hospital of Neuropsychiatry, Craiova, Romania.
authors.forename: Cornelia
authors.initials: C
authors.lastname: Zaharia
keywords: ischemic stroke; low molecular weight heparins; venous thrombosis embolism